Cytek Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio534.4941969.36
Forward P/E26.1444.39152.95
P/S Ratio4.176.418.3917.06
P/B Ratio2.113.153.235.38
Price/Tangible Book2.333.493.355.59
Price/FCF38.251952.948204.54
Price/OCF32.94234.09471.36
Enterprise Value Ratios
EV/Revenue2.864.996.4114.12
EV/EBITDA1527.81173.67
EV/EBIT197.22
EV/FCF26.211522.106789.29
Profitability & Returns
Return on Equity (ROE)-0.02%-0.03%0.01%0.01%0.18%
Return on Assets (ROA)-0.03%-0.03%0.00%0.02%0.06%
Return on Invested Capital (ROIC)-0.17%-0.23%-0.02%0.17%1.27%
Return on Capital Employed (ROCE)-0.05%-0.06%0.00%0.02%0.07%
Leverage & Solvency Ratios
Debt/Equity0.040.040.040.02
Debt/EBITDA4.230.19
Debt/FCF0.7822.330.20
Liquidity Ratios
Current Ratio5.866.979.2613.017.86
Quick Ratio5.005.677.9911.886.91
Efficiency Ratios
Asset Turnover0.400.380.330.380.64
Inventory Turnover1.701.521.551.751.96
Yield & Distribution Ratios
Earnings Yield-0.01%-0.01%0.00%0.00%
FCF Yield0.03%0.00%-0.02%0.00%
Buyback Yield0.03%0.02%-0.70%-1.50%-0.17%